Clinical trial
Abciximab in Wake-up Stroke
NCT00167765 · University of Zurich, Other · Terminated
Key facts
| NCT number | NCT00167765 |
|---|---|
| Title | Abciximab in Wake-up Stroke |
| Official title | Does Abciximab Save Hypoperfused Ischemic Brain Tissue in Wake-Up Stroke: A Placebo-Controlled, Randomized, MR Imaging Study |
| Lead sponsor | University of Zurich, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Drug |
| Interventions | Abciximab |
| Enrollment | 50 |
| Start date | Mar 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | May 3, 2007 |
| Countries | Germany, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: